Cadrenal Therapeutics(us:CVKD)
16.17
+11.59%
Updated on 2024-12-22
Open:15.89
Close:16.17
High:18.00
Low:15.33
Pre Close:14.49
Volume:202023.00
Amount:3.38M
Turnover:11.33%
Shares:1.78M
MarketCap:28.82M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 12 | 23348 | 0.15% | 2 | 3 | 6 |
| 2024-03-31 | 10 | 1697434 | 10.60% | 4 | 5 | 0 |
| 2023-12-31 | 10 | 551676 | 4.24% | 1 | 2 | 5 |
| 2023-09-30 | 9 | 1106106 | 8.49% | 6 | 3 | 0 |
| 2023-06-30 | 3 | 284 | 0.00% | 0 | 0 | 2 |
| 2023-03-31 | 3 | 847 | 0.01% | 3 | 0 | 0 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Armistice Capital, Llc | 1349586 | 8.43% | 935301 | 225.76% |
| 2024-03-31 | Renaissance Technologies Llc | 148138 | 0.93% | 69038 | 87.28% |
| 2024-03-31 | Citadel Advisors Llc | 55848 | 0.35% | 55848 | |
| 2024-03-31 | Geode Capital Management, Llc | 42865 | 0.27% | 4120 | 10.63% |
| 2024-03-31 | Virtu Financial Llc | 32380 | 0.20% | 32380 | |
| 2024-03-31 | Avantax Planning Partners, Inc. | 28305 | 0.18% | 28305 | |
| 2024-03-31 | Xtx Topco Ltd | 19738 | 0.12% | 19738 | |
| 2024-03-31 | Biltmore Family Office, Llc | 11000 | 0.07% | 0 | |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 9520 | 0.06% | 1027 | 12.09% |
| 2024-03-31 | Wells Fargo & Company/Mn | 54 | 0.00% | 1 | 1.89% |
About
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang Pham and Matthew Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.
Address:822 A1A North,Suite 306
Website:http://www.cadrenal.com
Market Movers